A look at top cues from the domestic and international markets that could have a bearing on D-Street today.
According to a notification issued by the US Food and Drug Administration (USFDA), as many as 24,652 tablets are being recalled under 'class-I' classification.
The Dow Jones Industrial Average rose 0.3 percent to end at 22,092.81, an all-time high. The S&P 500 gained 0.19 percent to 2,476.83 and the Nasdaq Composite added 0.18 percent to 6,351.56.
Strong demand in the United States provided prices with support, traders said, but ongoing high supplies from OPEC producers were restricting further gains.
"Zydus Cadila has commercially launched its mesalamine delayed release tablets in the US market. Zydus was the first to file an Abbreviated New Drug Application (ANDA) for the generic version of Lialda," the company said in a BSE filing today.
Dow Jones Industrial Average closed down 2.53 points, or 0.01 percent, to 21,394.76, the S&P 500 gained 3.8 points, or 0.16 percent, to 2,438.3 and the Nasdaq Composite added 28.57 points, or 0.46 percent, to 6,265.25.
Technology stocks sold off sharply on Friday, taking a toll on the Nasdaq and dragging on other major Wall Street indexes, which touched record highs earlier in the day. Dow Jones Industrial Average rose 89.44 points, or 0.42 percent, to 21,271.97, while the S&P 500 lost 2.02 points, or 0.08 percent, to 2,431.77.
Dow Jones Industrial Average rose 62.11 points, or 0.29 percent, to 21,206.29, the S&P 500 gained 9.01 points, or 0.37 percent, to 2,439.07 and the Nasdaq Composite added 58.97 points, or 0.94 percent, to 6,305.80.
The company has received final approval from the United States Food and Drug Administration (USFDA) to market Cyproheptadine Hydrochloride tablets in the strength of 4 mg, Cadila Healthcare said in a BSE filing.
The parent company of Amazon India, now sells over 40 million products from India in different categories like textiles, leather and organic products.
In a BSE filing, Unichem Laboratories said "it has received ANDA approval from the United States Food and Drug Administration (USFDA) for Piroxicam Capsules USP 10mg and 20mg".
Dow Jones Industrial Average fell 11.38 points, or 0.06 percent, to 20,651.84, the S&P 500 lost 3.8 points, or 0.16 percent, to 2,358.92 and the Nasdaq Composite dropped 17.06 points, or 0.29 percent, to 5,894.68.
Sun Pharma and Cadila Healthcare are recalling one product each from the US market due to contamination and presence of "foreign" tablets respectively.
US stocks struggled last week as President Donald Trump failed to gather majority on health care reform in Congress which raised questions about his ability to push through other key reforms promised in his election campaigns such as tax cuts and fiscal spending to boost the economy.
Dow Jones Industrial Average closed down 59.86 points, or 0.29 percent, at 20,596.72. The S&P 500 closed down 1.98 points, or 0.08 percent, at 2,343.98. The Nasdaq Composite ended 11.05 points higher, or 0.19 percent, at 5,828.74.
The focus is to look at companies that have the potential to grow significant cash flows over the medium to long-term, say 5-10 years, says Jeff Chowdhry, Senior Portfolio Manager, LGM Investments.
"Glenmark Pharmaceuticals Inc USA and Evestra Inc have completed a strategic development, licence and commercialisation agreement to develop and market a generic version of Merck & Co's NuvaRing product -- etonogestrel and ethinyl estradiol vaginal ring...," Glenmark Pharmaceuticals said in a statement.
Umang Vohra of Cipla reasoned that almost 80 percent of the drugs sold by Cipla in the US market are manufactured in the US itself. He said it will not be a challenge to manufacture all its supplies in the US itself if asked to do so by authorities.
Mark Matthews of Bank Julius Baer is positive on India. A strong base effect coming from commodities and the banking space is the reason for his optimism.
Piramal Enterprises has been on an acquisition spree and the company's COO said that there is no cash constraint for acquisitions.
Tata Motors-owned Jaguar Land Rover, which also relies on exports from the UK to serve the US customer, will be impacted heavily if Trump has his way.
Wall Street's main stock indexes rose to fresh all-time closing highs on Friday as a spike in oil prices supported energy shares and investors renewed their optimism about President Donald Trump's economic agenda.
US stocks climbed on Friday, with the S&P 500 closing just short of a record high, boosted by gains in financial shares as President Donald Trump moved ahead with deregulation action and by a strong payrolls report.
In an interview with CNBC-TV18, Pankaj R Patel, CMD, Zydus Cadila Healthcare, talked about the company's business strategy, progress with molecule research and earnings outlook.